Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
+16.97%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.78B
Cap. Flow %
-0.6%
Top 10 Hldgs %
22.42%
Holding
3,363
New
106
Increased
1,797
Reduced
1,249
Closed
100

Top Buys

1
MSFT icon
Microsoft
MSFT
$1.04B
2
AAPL icon
Apple
AAPL
$880M
3
MRK icon
Merck
MRK
$323M
4
MDT icon
Medtronic
MDT
$317M
5
AMZN icon
Amazon
AMZN
$314M

Sector Composition

1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.19%
5 Communication Services 9.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GTT
3026
DELISTED
GTT Communications, Inc.
GTT
$474K ﹤0.01%
132,950
-2,951
-2% -$10.5K
EBMT icon
3027
Eagle Bancorp Montana
EBMT
$140M
$465K ﹤0.01%
21,952
+11,893
+118% +$252K
GENC icon
3028
Gencor Industries
GENC
$237M
$465K ﹤0.01%
37,797
+6,265
+20% +$77.1K
SAMG icon
3029
Silvercrest Asset Management
SAMG
$134M
$463K ﹤0.01%
33,325
+887
+3% +$12.3K
AVEO
3030
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$463K ﹤0.01%
80,268
+18,632
+30% +$107K
TYME
3031
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$462K ﹤0.01%
378,776
+11,716
+3% +$14.3K
ALGS icon
3032
Aligos Therapeutics
ALGS
$78.8M
$458K ﹤0.01%
+662
New +$458K
FCAP icon
3033
First Capital
FCAP
$145M
$458K ﹤0.01%
7,569
AVTX icon
3034
Avalo Therapeutics
AVTX
$153M
$457K ﹤0.01%
60
+1
+2% +$7.62K
ALR
3035
DELISTED
AlerisLife Inc. Common Stock
ALR
$457K ﹤0.01%
66,294
+18,290
+38% +$126K
CMCT
3036
Creative Media & Community Trust
CMCT
$5.34M
$456K ﹤0.01%
131
+3
+2% +$10.4K
ELMD icon
3037
Electromed
ELMD
$204M
$452K ﹤0.01%
46,086
+21,370
+86% +$210K
CRD.A icon
3038
Crawford & Co Class A
CRD.A
$540M
$451K ﹤0.01%
61,031
+3,011
+5% +$22.3K
TLPH icon
3039
Talphera
TLPH
$11.3M
$451K ﹤0.01%
18,171
+88
+0.5% +$2.18K
ESSA
3040
DELISTED
ESSA Bancorp
ESSA
$447K ﹤0.01%
29,831
+291
+1% +$4.36K
PBIP
3041
DELISTED
Prudential Bancorp, Inc.
PBIP
$446K ﹤0.01%
32,218
-115
-0.4% -$1.59K
MLSS icon
3042
Milestone Scientific
MLSS
$48.5M
$445K ﹤0.01%
209,760
+39,821
+23% +$84.5K
DHX icon
3043
DHI Group
DHX
$143M
$439K ﹤0.01%
197,810
+4,058
+2% +$9.01K
INZY
3044
DELISTED
Inozyme Pharma
INZY
$439K ﹤0.01%
21,292
+4,222
+25% +$87.1K
PAND
3045
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$438K ﹤0.01%
29,522
+19,241
+187% +$285K
ELOX
3046
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$435K ﹤0.01%
2,732
+37
+1% +$5.89K
ITRN icon
3047
Ituran Location and Control
ITRN
$672M
$433K ﹤0.01%
22,716
MIRM icon
3048
Mirum Pharmaceuticals
MIRM
$3.82B
$433K ﹤0.01%
24,811
-135
-0.5% -$2.36K
AC icon
3049
Associated Capital Group
AC
$652M
$429K ﹤0.01%
12,218
-46
-0.4% -$1.62K
ORGS
3050
DELISTED
Orgenesis Inc. Common Stock
ORGS
$428K ﹤0.01%
9,509
+273
+3% +$12.3K